Logotype for Athanase Innovation

Athanase Innovation (ATIN) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Athanase Innovation

Q4 2024 earnings summary

5 Jun, 2025

Executive summary

  • Net revenue for Q4 2024 was SEK 29.4m, up from SEK 15.8m in Q4 2023; full-year revenue reached SEK 115.3m, up from SEK 19.3m year-over-year.

  • Value change from securities was SEK 21.0m in Q4 (SEK 2.6m in Q4 2023) and SEK 53.5m for the year (SEK 21.3m in 2023).

  • Operating result (EBIT) improved to SEK -0.01m in Q4 (SEK -27.3m in Q4 2023) and SEK -23.7m for the year (SEK -79.2m in 2023).

  • CEO transition: Peter Laveson stepped down, Daniel Nyhrén Edeen appointed as interim CEO.

  • Voluntary redemption program returned SEK 91.8m to shareholders; 3.8m shares redeemed at SEK 24 per share.

Financial highlights

  • Ivisys, the wholly owned subsidiary, contributed all group revenue, completing several installations and selling 10 PalletAl units in 2024 (4 in 2023).

  • Group cash flow for Q4 was SEK -115.4m (SEK -80.4m in Q4 2023); year-to-date cash flow was SEK -146.1m (SEK -179.3m in 2023).

  • Cash and cash equivalents at year-end were SEK 310.6m (SEK 457.2m at end 2023).

  • Earnings per share for Q4 was SEK -0.02 (SEK -0.48 in Q4 2023); for the year, SEK -0.83 (SEK -1.89 in 2023).

  • Equity ratio at year-end was 87.8% (92.8% at end 2023).

Outlook and guidance

  • Ivisys order book at year-end was SEK 26.6m; additional orders received after the period.

  • The board is evaluating a potential tax-free distribution of subsidiaries via Lex Asea and will await tax authority feedback before proceeding with delisting plans.

  • No dividend proposed for 2024.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Athanase Innovation